NDC 70710-1272-2 - sacubitril and valsartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1272
- Requested NDC
- 70710-1272-2
- Package NDCs from labels
- 70710-1272-6, 70710-1272-8, 70710-1272-2, 70710-1272-4
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2025-07-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SACUBITRIL - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2025-07-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1272-2 | sacubitril and valsartan | 10 in 1 BLISTER PACK | TABLET | 10 | 2 | |
| 70710-1272-4 | sacubitril and valsartan | 10 in 1 CARTON | TABLET | 10 | 2 | |
| 70710-1272-6 | sacubitril and valsartan | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 70710-1272-8 | sacubitril and valsartan | 180 in 1 BOTTLE | TABLET | 180 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1272-6 | EA - Each | 70710-1272 | e77ac854-ee51-4784-81a5-d4585d3eb725 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan | VALSARTAN | Coupler LLC | 3dfe5407-96a6-d2f4-e063-6294a90aa810 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Dolce and Gabbana Everlast Foundation SPF 20 38C Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 0358a87d-8002-4f3e-851a-3a582d356edf | 2025-09-03 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 39N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 34dfc4c5-44f7-4531-97ba-8846ebe14724 | 2025-09-03 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 40C Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | cf4b6f45-d4ae-4665-87b4-c5af4910befa | 2025-09-03 | Warnings | 15FIX9V2JP |
| Pure6 ManiShield Hand Screen | ZINC OXIDE, TITANIUM DIOXIDE | GUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD | 3abcb6ba-1de8-55e7-e063-6294a90aecf1 | 2025-09-02 | Warnings | 15FIX9V2JP |
| Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Aphena Pharma Solutions - Tennessee, LLC | 3cf9da3f-42b7-df11-e063-6294a90ad40b | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | 1656349 17ERJ0MKGI 80M03YXJ7I |
| Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Aphena Pharma Solutions - Tennessee, LLC | 3cfa68eb-6167-e7ed-e063-6294a90a27f6 | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | 1656340 17ERJ0MKGI 80M03YXJ7I |
| toty Ilumina CC Creamy Compact 6N | TITANIUM DIOXIDE | Chipican LLC | 3da732e7-19b0-3195-e063-6394a90a9a0c | 2025-09-01 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 4 | ENSULIZOLE ,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dba1360-f70f-e450-e063-6394a90a8c9f | 2025-09-01 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 33N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | e249507c-d536-4c1d-a99d-857ca1e833d8 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 32W Medium Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | ba99edea-bf68-4118-8bb7-ea40322db46a | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 34W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3a239897-9850-417f-8c00-e810a52540c1 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 36N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | c495afc3-6486-4652-b743-958f28eccaca | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 35W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 5440ed13-b07e-4c81-a407-d9ac68eaa483 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 37W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 9b2c4567-fde7-4b76-9988-b2cba2d3747e | 2025-08-29 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 2 | ENSULIZOLE,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3d55291c-9d4c-85c3-e063-6394a90af330 | 2025-08-27 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 3 | ENSULIZOLE ,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3d565612-ade5-bfb3-e063-6294a90a0c65 | 2025-08-27 | Warnings | 15FIX9V2JP |
| Sun Bum 30 Mineral Tinted Sunscreen Face | TITANIUM DIOXIDE, ZINC OXIDE | Sun Bum, LLC | 3a290aad-7f40-cb10-e063-6394a90a2e69 | 2025-08-27 | Warnings | 15FIX9V2JP |
| Valsartan | VALSARTAN | Solco Healthcare US, LLC | 26080940-bcd3-446d-9026-3ddfb58e281e | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Allergy and Sinus Relief | PELARGONIUM SIDOIDES ROOT, HYDRASTIS CANADENSIS WHOLE, POTASSIUM CHLORIDE, SANGUINARIA CANADENSIS ROOT, PULSATILLA VULGARIS, SILICON DIOXIDE | Schwabe North American, Inc. | c90cc6f5-14ec-41a3-a20a-4e8018bb02fb | 2025-08-25 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.